Prognostic Value Of Disease Status At Time Of Allogeneic Transplant For Relapsed Non-Hodgkin's Lymphoma

被引：0
|
作者：
Bakhos, Shams
Aleah, Brubaker L.
Parthasarathy, Mala
Go, Aileen
Rodriguez, Tulio E.
Stiff, Patrick J.
Smith, Scott E.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3412.3412
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3412
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Schiepers, Christiaan
    Filmont, Jean-Emmanuel
    Czernin, Johannes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S82 - S88
  • [42] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Christiaan Schiepers
    Jean-Emmanuel Filmont
    Johannes Czernin
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S82 - S88
  • [43] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Hoskin, P. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 : S37 - S41
  • [44] The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
    Beard S.M.
    Lorigan P.C.
    Sampson F.C.
    British Journal of Cancer, 2000, 82 (1) : 81 - 84
  • [45] POSITRON EMISSION TOMOGRAPHY (PET) PERFORMED BEFORE ALLOGENEIC TRANSPLANTATION HAS A PROGNOSTIC ROLE IN PATIENTS WITH RELAPSED AND CHEMOSENSITIVE HODGKIN LYMPHOMA OR AGGRESSIVE NON-HODGKIN LYMPHOMA
    Dodero, A.
    Crocchiolo, R.
    Patriarca, F.
    Castagna, L.
    Ciceri, F.
    Frungillo, N.
    Fanin, R.
    Bramanti, S.
    Miceli, R.
    Assanelli, A.
    Milani, R.
    Crippa, F.
    Corradini, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 248 - 248
  • [46] The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
    Beard, SM
    Lorigan, PC
    Sampson, FC
    BRITISH JOURNAL OF CANCER, 2000, 82 (01) : 81 - 84
  • [47] Positron emission tomography scan performed before reduced-intensity conditioning allogeneic stem cell transplantation has a prognostic value in patients with relapsed and chemosensitive Hodgkin's lymphoma or aggressive non-Hodgkin lymphoma
    Dodero, A.
    Crocchiolo, R.
    Patriarca, F.
    Castagna, L.
    Ciceri, F.
    Frungillo, N.
    Fanin, R.
    Bramanti, S.
    Miceli, R.
    Assanelli, A.
    Milani, R.
    Crippa, F.
    Corradini, P.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S42 - S43
  • [48] Autologous bone marrow transplantation in relapsed non-Hodgkin's lymphoma
    Atkins, CD
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15): : 990 - 990
  • [49] Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    Wiernik, Peter H.
    Lossos, Izidore S.
    Tuscano, Joseph M.
    Justice, Glen
    Vose, Julie M.
    Cole, Craig E.
    Lam, Wendy
    McBride, Kyle
    Wride, Kenton
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Habermann, Thomas M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4952 - 4957
  • [50] Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphoma
    Weidmann, E
    Kim, SZ
    Rost, A
    Schuppert, H
    Seipelt, G
    Hoelzer, D
    Mitrou, PS
    ANNALS OF ONCOLOGY, 2002, 13 (08) : 1285 - 1289
12345